4355 Maryland Ave. Suite #105
St. Louis, MO. 63108

Drug Design Methodologies, LLC. is a St. Louis, Missouri based privately held company headed by Dr. Chris Ho.

 

Dr. Ho has over fifteen years of expertise in the application and development of computational tools for drug design. During his doctoral training with Professor Garland R. Marshall at Washington University - St. Louis, he wrote numerous software packages for ligand-receptor visualization, 3D database searching, combinatorial database design, and structure-based ligand design.  In addition, through collaborative agreements with the pharmaceutical industry (Monsanto Co, Parke-Davis Research, Fisons), he gained valuable experience and insight into the scientific needs of computational chemists.  Soon after completing his doctorate and medical degrees in 1996, he formed Drug Design Methodologies to put his computational chemistry experience and ideas into practice.
 

Our mission is to develop the most technically advanced computer-aided drug refinement tools to streamline the lead optimization process. We work hand-in-hand with collaborators in the top pharmaceutical companies in order to ensure that the tools we develop are optimized for extensive practical application, utility, and ease of use.

 

Our strengths are in the creation of technologies that empower the user by exploiting his or her proprietary data to afford a distinct edge over the competition.